Dosing Flexibility Study in Patients With Rheumatoid Arthritis
Status: | Completed |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/4/2018 |
Start Date: | December 2007 |
End Date: | March 2011 |
A Phase IIIb Open-label run-in Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety/Efficacy of Certolizumab Pegol Administered Concomitantly With Stable-dose Methotrexate in Patients With Active Rheumatoid Arthritis.
During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and
4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and
16. At Wk 18 patients will be grouped as responders or non-responders based on results of the
ACR20 at Week 16.
4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and
16. At Wk 18 patients will be grouped as responders or non-responders based on results of the
ACR20 at Week 16.
Subjects with a stable methotrexate (MTX) dose enter the run-in period in which certolizumab
pegol (CZP) will be administered at a dose of 400 mg (2 injections) at Weeks 0, 2, and 4 and
at a dose of 200 mg with placebo (1 injection placebo, 1 injection CZP) at Weeks 6, 8, 10,
12, 14 and 16. The dose of MTX should be stable for at least 2 months prior to the Baseline
visit and will remain stable throughout the trial, unless there is a need to reduce the dose
for reasons of toxicity.
At the Week 18 visit, subjects who were ACR20 (American College of Rheumatology 20%
Improvement) responders at Week 16 will be randomized in a double-blinded way to receive
either 400 mg CZP given every 4 weeks and placebo given every 4 weeks given as two injections
(alternating CZP and placebo every two weeks) plus MTX, 200 mg CZP and placebo administered
every 2 weeks (one injection of each) plus MTX, or Placebo administered as two injections
every 2 weeks plus MTX. Non-responders will be withdrawn from the study.
pegol (CZP) will be administered at a dose of 400 mg (2 injections) at Weeks 0, 2, and 4 and
at a dose of 200 mg with placebo (1 injection placebo, 1 injection CZP) at Weeks 6, 8, 10,
12, 14 and 16. The dose of MTX should be stable for at least 2 months prior to the Baseline
visit and will remain stable throughout the trial, unless there is a need to reduce the dose
for reasons of toxicity.
At the Week 18 visit, subjects who were ACR20 (American College of Rheumatology 20%
Improvement) responders at Week 16 will be randomized in a double-blinded way to receive
either 400 mg CZP given every 4 weeks and placebo given every 4 weeks given as two injections
(alternating CZP and placebo every two weeks) plus MTX, 200 mg CZP and placebo administered
every 2 weeks (one injection of each) plus MTX, or Placebo administered as two injections
every 2 weeks plus MTX. Non-responders will be withdrawn from the study.
Inclusion Criteria:
- Patients with established adult rheumatoid arthritis currently on Methotrexate for at
least 3 months
Exclusion Criteria:
- All concomitant diseases or pathological conditions that could interfere and impact
the assessment of the study treatment
- Previous clinical trials participation and previous biological therapy that could
interfere with the results of the present clinical trial
We found this trial at
51
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials